Vincere Biosciences
PrivateLast Round
Grant
Nov 18, 2025
Total Funding Raised
$7.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vincere Biosciences is a biotechnology company that develops small molecule therapeutics to treat age-related diseases, such as Parkinson's, by enhancing mitochondrial quality control.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vincere Biosciences Comparables
Compare Vincere Biosciences with similar companies based on industry and business-model similarity.
Vincere Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 18, 2025 | ||||
| Strategic | May 22, 2025 | ||||
| Grant | Sep 25, 2023 | ||||
| Strategic | Jun 12, 2023 | ||||
| Grant | Jun 27, 2022 | ||||
Grant | Apr 13, 2020 |
Vincere Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LongGame Ventures | Grant |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| National Institute on Aging | Grant |
| Draper Associates | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
Secured $5M in grant funding.
- Jun 27, 2022
$300K grant from the National Institute on Aging.
Vincere Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vincere Biosciences's valuation, stock price, and market status.